4.19.2023 Board Book

7173 S. Havana St. | Ste. 600-130 Centennial, CO 80112 P: 303.770.2526 | F: 303.779.4834 obesitymedicine.org

EXHIBITOR ACCEPTANCE RULES AND REGULATIONS

Purpose: The Obesity Medicine Association (OMA) is a professional medical association that enlists companies who seek to advance and support the treatment of patients affected by obesity. These Rules and Regulations are for internal committee review purposes only, and are not intended to be shared publicly via the OMA website, prospectus, etc. Process: New applications will be reviewed by the Exhibitor Acceptance Review Committee (the “Committee”). The Committee consists of the six non -executive members of the Board of Trustees. One of these members will be appointed by the OMA president to serve as the chairperson of the Committee. The Committee will be divided into 3 topic-based subgroups comprised of 2 individuals each. If the subgroup approves the application, the subgroup will notify the chairperson who in turn notifies OMA staff, and the exhibitor will be granted approval. If the subgroup finds the application to be questionable or denies the application, the subgroup will notify the chairperson, and the entire Committee will be asked to evaluate the application. The Committee retains sole authority to determine eligibility and reserves the right to request additional data from applicants as needed. Committee Responsibilities: The primary responsibility of the Committee is to evaluate applications to determine whether the product or service will serve to advance and improve the professional standards of the practice of obesity medicine. In addition, the product or service must align with these Rules and Regulations, conform to OMA practice position statements, and be germane to the goal of OMA, which is to promote and advance the standards of obesity medicine. Specifically, the duties, responsibilities, and authority of the Committee are as follows: • Review all applications and the related products and services • Evaluate whether the product or service the applicant wishes to promote is consistent with the guidelines stated below • Provide OMA staff with a vote of approval or disapproval, with justification for either case. A majority vote of the Committee shall constitute a quorum. In the case of disapproval, OMA staff will notify OMA’s Exe cutive Director. 1. Product requires marketing approval by the Food and Drug Administration (FDA) a. Examples include pharmaceuticals, medical devices, and other FDA-regulated products. b. Product must first receive FDA approval to be eligible for marketing opportunities. It is the responsibility of the applicant to conform to FDA regulations and all legal requirements for the content of claims made about the product. However, companies awaiting FDA approval may apply to sponsor various activities at the discretion of the Committee, as long as the product awaiting FDA approval is not actively promoted. c. The Committee reserves the right to deny an application if the product is currently under investigation or scrutiny by any state board of medicine or the FDA. 2. Nutritional product Acceptance Guidelines: Depending on the category, the committee will evaluate the product or service based on the following guidelines: